Study candidate plants
Phase one is designed to study wild-type candidate species associated with lectin research and plant-based protein production, assessing their suitability under local conditions.
● A TRILLION CELLS R&D INITIATIVE
Bridging the
biomanufacturing
gap in Africa
Plant science. Local knowledge. A shared ambition for better biomedical access across Africa.
Proposed transgenic plant research.
PLANT BIOTECHNOLOGY✳LOCALLY GROUNDED RESEARCH✳AFRICAN BIOINNOVATION
01 / WHY IT MATTERS
Biomedical access
starts with capacity.
Our mission is to help bridge the gap between the biomedical products Africa needs and the capacity to produce them locally.
Create Biomedicines, the biotechnology division of Trillion Cells, is proposing a cost-effective, scalable plant-based molecular farming research platform near Monrovia, Liberia.
The ambition is to explore how plants could support future local production of proteins for diagnostic and therapeutic applications—building knowledge and research capability close to the communities we hope to serve.
See the path forward ↗02 / THE SCIENTIFIC APPROACH
First, understand
the plants.
Observe the environment
Track local climate, seasonal variation, and extreme weather alongside plant development to understand how environmental conditions influence performance.
Build the evidence
Record growth rates, stress responses, and overall plant health through consistent field observations and structured environmental and physiological datasets.
Observation comes first. Phase-one wild-type field research does not demonstrate recombinant protein expression, manufacturing readiness, or therapeutic performance.
03 / RESEARCH ROADMAP
From field insight
to future potential.
PHASE 01 · FOUNDATIONAL RESEARCH
Establish the field foundation
Study wild-type candidate plants near Monrovia. Compare growth, stress, and health across climate conditions and seasons to inform future platform design.
PHASE 02 · PROPOSED NEXT STEP
Evaluate molecular farming feasibility
Use field insights to inform candidate selection and future studies of target proteins, including lectins and monoclonal antibodies. Protein expression and performance would require separate evaluation.
PHASE 03 · LONGER-TERM AMBITION
Explore a path toward production
Investigate scalable production and downstream recovery, purification, and quality assessment, subject to feasibility, infrastructure, funding, and relevant regulatory requirements.
● Platform status: proposed research initiative. Production and downstream capabilities are goals; they are not presented as validated or operational.
04 / A LOCAL FOUNDATION
Beginning in Liberia.
Thinking across Africa.
Our proposed platform near Monrovia begins with a practical question: how can plant science, studied in local conditions, help build a foundation for future biomedical manufacturing?
The site sign expresses that ambition. The research ahead must establish what is feasible, what can be reproduced, and what it would take to move responsibly toward scale.
↗ Near Monrovia, Liberia
05 / PARTNERSHIPS & COLLABORATION
Progress grows
through partnership.
We welcome conversations with researchers, institutions, and partners who share an interest in locally grounded biotechnology and a stronger biomedical future for Africa.
Start a conversation ↗Scientific collaboration
Plant biotechnology, molecular farming, and field research.
Institutional partnerships
Research design, training, and shared scientific capacity.
Strategic support
Resources and expertise to help evaluate the proposed platform.